These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 31888350

  • 1. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Covvey JR, Erickson O, Fiumara D, Mazzei K, Moszczenski Z, Slipak K, Nemecek BD, Zimmerman DE, Guarascio AJ.
    Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Implementation of vancomycin AUC/MIC dosing vs traditional trough dosing and incidence of acute kidney injury at a rural community hospital.
    McClure S, McElroy L, Gugkaeva Z.
    Am J Health Syst Pharm; 2024 May 24; 81(11):e283-e288. PubMed ID: 38253056
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association between single trough-based area under the curve estimation of vancomycin and treatment outcome among methicillin-resistant Staphylococcus aureus bacteremia patients.
    Makmor-Bakry M, Ahmat A, Shamsuddin A, Lau CL, Ramli R.
    Anaesthesiol Intensive Ther; 2019 May 24; 51(3):218-223. PubMed ID: 31434472
    [Abstract] [Full Text] [Related]

  • 6. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
    Tsutsuura M, Moriyama H, Kojima N, Mizukami Y, Tashiro S, Osa S, Enoki Y, Taguchi K, Oda K, Fujii S, Takahashi Y, Hamada Y, Kimura T, Takesue Y, Matsumoto K.
    BMC Infect Dis; 2021 Feb 06; 21(1):153. PubMed ID: 33549035
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R, So H, Seo E, Kim M, Lee J.
    PLoS One; 2021 Feb 06; 16(4):e0247714. PubMed ID: 33793589
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?
    Johnston MM, Huang V, Hall ST, Buckley MS, Bikin D, Barletta JF.
    Diagn Microbiol Infect Dis; 2021 Oct 06; 101(2):115442. PubMed ID: 34192639
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant].
    Lepe JA, Gil-Navarro MV, Santos-Rubio MD, Bautista J, Aznar J.
    Rev Esp Quimioter; 2010 Mar 06; 23(1):43-7. PubMed ID: 20232023
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia.
    Beccari MV, Seabury RW, Mogle BT, Kufel WD, Miller CD, Steele JM.
    J Am Pharm Assoc (2003); 2020 Mar 06; 60(5):729-733. PubMed ID: 32224054
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?
    Lodise TP, Drusano GL, Zasowski E, Dihmess A, Lazariu V, Cosler L, McNutt LA.
    Clin Infect Dis; 2014 Sep 01; 59(5):666-75. PubMed ID: 24867791
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ.
    Clin Ther; 2016 Jan 01; 38(1):16-30. PubMed ID: 26585355
    [Abstract] [Full Text] [Related]

  • 19. Dosing vancomycin in the super obese: less is more.
    Crass RL, Dunn R, Hong J, Krop LC, Pai MP.
    J Antimicrob Chemother; 2018 Nov 01; 73(11):3081-3086. PubMed ID: 30203073
    [Abstract] [Full Text] [Related]

  • 20. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
    Kullar R, Davis SL, Levine DP, Rybak MJ.
    Clin Infect Dis; 2011 Apr 15; 52(8):975-81. PubMed ID: 21460309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.